Final preparations are underway as BestCities Global Alliance, visitBerlin – one of the Alliance’s partner destinations – and leading Professional Conference Organiser, Kenes Group, get ready to welcome delegates to their inaugural original event in Berlin.
Senior level attendees from leading international pharma and biotech companies, academia and government institutions are expected at the Summit on Controversies in Precision Medicine (CPMed), due to take place at the Ameron Hotel Abion Spreebogen Waterside, 13-15 November 2017.
The Summit is the first event following a landmark agreement signed by Kenes and BestCities, to initiate and manage original events in the 12 BestCities global locations. With a shared ambition to deliver high-level meetings for doctors, researchers, and specialists, not formally structured through existing associations, the events are a unique opportunity to study a specialised area of expertise, providing a valuable knowledge sharing and networking platform.
Under the leadership of Prof. Dan Peer, Director of Tel Aviv University Cancer Biology Research Centre and Translational Medicine, CPMed will address the challenges in precision medicine head-on. Titled, “Where do we stand in drug development?”, the Summit will create a focused environment for quality and open scientific debate on the value and direction of the industry. With an interactive architecture, the event is designed to provide the participants with exciting opportunities to ignite solutions, network and innovate.
Work is already underway to initiate a number of future original events through the collaboration of BestCities, Kenes Group and high-profile opinion leaders from around the world, in key fields where there is a potential to create an original event.
Ravit Shani Levi, Director of Global Market Development at Kenes Group, said “CPMed is an important first step into initiating a series of original events that leave a legacy. Under Prof. Dan Peer’s leadership and the outstanding support from our partners at BestCities and visitBerlin, we are looking forward to this new original event becoming an innovative platform for knowledge exchange, education, and networking in the field of precision medicine.”
Paul Vallee, Managing Director of BestCities, said: “Working together with Kenes, BestCities is committed to delivering impactful meetings that offer genuine value, insight and innovation to the global medical community. With its focus on a niche but crucial topic, CPMed is the ideal first event to showcase BestCities and Kenes shared long-term ambition for initiated conferences and our commitment to help build lasting legacies between associations and destinations.”
Burkhard Kieker, CEO of visitBerlin, said: “Berlin is known around the world as a centre for innovation and has a first-class network of universities and research centres. This is particularly beneficial for meetings related to science and medicine. In addition, the city offers affordable accommodation compared to other cities and a wide range of cultural offerings. This unique blend is convincing an increasing number of convention and event organisers. Berlin is proud to be a strong partner in the new BestCities initiative with Kenes Group.”
For more information on CPMed visit: www.precisionmedicine.kenes.com